Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indications for bone marrow grafting

M Boiron, E Gluckman

    Bulletin Du Cancer
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Bone marrow transplantation is a key treatment for severe aplastic anemia and acute leukemia. Current survival rates exceed 50%, with ongoing research to improve outcomes for transplant patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

    Annals of the rheumatic diseases·2007
    Same author

    Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

    Annals of the rheumatic diseases·2007
    Same author

    Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

    Bone marrow transplantation·2007
    Same author

    Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.

    Bone marrow transplantation·2007
    Same author

    Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

    Bone marrow transplantation·2007
    Same author

    [Clinical research at the European LeukemiaNet].

    Deutsche medizinische Wochenschrift (1946)·2006
    Same journal

    [ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

    Bulletin du cancer·2026
    Same journal

    [Off-label use of venetoclax in myeloma].

    Bulletin du cancer·2026
    Same journal

    [Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

    Bulletin du cancer·2026
    Same journal

    Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

    Bulletin du cancer·2026
    Same journal

    [Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

    Bulletin du cancer·2026
    Same journal

    [Reirradiation: A new therapeutic paradigm in oncology].

    Bulletin du cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Bone marrow transplantation (BMT) has emerged as a significant therapeutic option.
    • Primary indications include severe aplastic anemia and acute leukemia in complete remission.

    Purpose of the Study:

    • To review the current status and indications of bone marrow transplantation.
    • To highlight challenges and advancements in managing BMT complications.

    Main Methods:

    • Review of established BMT protocols and clinical outcomes.
    • Analysis of patient data for survival rates and complication management.

    Main Results:

    • BMT is primarily indicated for severe aplastic anemia and acute leukemia.

    Related Experiment Videos

  • HLA-identical sibling donors remain the standard for transplantation.
  • Long-term survival rates currently exceed 50%.

    • Conclusions:

    • Bone marrow transplantation offers a viable treatment for specific hematologic conditions.
    • Continued research is crucial for mitigating complications like graft-versus-host disease and interstitial pneumonitis.
    • Improving donor selection and post-transplant care is essential for enhancing patient survival.